Retracted article: Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025

Eurosurveillance 2026 Open access

Read full text
Authors: Ying Shen, Daitao Zhang, Zhaomin Feng, Chunna Ma, Weixian Shi, Wei Duan, Jie Li, Lu Zhang, Dan Wu, J J Zhang, Jiaxin Ma, Yingying Wang
+7 more Xiaodi Hu, Shuning Yan, Yuanzhi Di, Jiachen Zhao, Hui Xu, Quanyi Wang, Peng Yang
DOI: 10.2807/1560-7917.es.2026.31.2.2500993
Cited by: 5
References: 11

Abstract

During the early 2025/26 influenza season, influenza A(H3N2) subclade K rapidly predominated in Beijing, China. Using a test-negative design, we estimated influenza vaccine effectiveness (VE) among influenza-like illness outpatients tested between September and December 2025. Among 9,579 participants, sequencing of 316 randomly selected A(H3N2)-positive samples showed 84.8% were subclade K, and antigenic analysis of 65 viruses indicated antigenic divergence. Despite this, adjusted VE against laboratory-confirmed influenza was 41.3% (95% CI: 29.2 to 51.3), indicating moderate protection during this subclade K-dominated season.

Fields of Study & Subjects

Influenza Virus Research Studies Respiratory viral infections research SARS-CoV-2 and COVID-19 Research

Publication details

Journal / source
Eurosurveillance
Publisher
European Centre for Disease Control and Prevention (ECDC)
Volume
31
Issue
2
Publication date
15 January 2026
Language
EN